Microgynon

Ethinylestradiol / Levonorgestrel, the active ingredients in Microgynon, are a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Microgynon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Microgynon, a combined oral contraceptive, is used to manage reproductive health and related hormonal conditions. - Prevention of pregnancy: provides reliable contraception for women of childbearing age. - Regulation of menstrual cycles: helps achieve more predictable bleeding patterns. - Treatment of moderate acne: reduces androgenic activity that contributes to acne lesions.

Microgynon may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Pulmonary embolism: clot migration to lungs. - Stroke: cerebrovascular accident. - Myocardial infarction: heart attack. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty. - Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Microgynon, clinicians should evaluate several safety considerations. - Assess cardiovascular risk: review history of thrombosis, hypertension, smoking, and age. - Screen for contraindications: exclude active liver disease, hormone‑sensitive cancers, or uncontrolled diabetes. - Consider age and smoking status: avoid use in women over 35 who smoke. - Review concomitant medications: identify drugs that may induce hepatic enzymes or affect clotting. - Educate on missed doses: provide clear instructions to maintain contraceptive efficacy. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Microgynon can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (carbamazepine, phenytoin, phenobarbital): may reduce contraceptive effectiveness. - Rifampicin and rifabutin: lower hormone levels, increasing risk of unintended pregnancy. - St. John’s wort: induces metabolism, potentially compromising efficacy.

Moderate Interactions (Monitor Closely): - Certain antibiotics (tetracycline, metronidazole): may slightly decrease hormone concentrations. - Azole antifungals (ketoconazole, itraconazole): can raise hormone levels, requiring monitoring for side effects.